Last 7 days
-6.2%
Last 30 days
-11.9%
Last 90 days
-11.8%
Trailing 12 Months
-12.1%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 448.8B | 335.9B | -0.30% | -2.84% | 21.68 | 1.34 | 12.90% | 18.65% |
CI | 91.1B | 183.0B | -1.64% | -7.76% | 13.64 | 1.92 | 3.34% | 24.58% |
CVS | 86.5B | 330.9B | -6.39% | -30.02% | 21.72 | 0.26 | 10.37% | -50.26% |
HUM | 65.7B | 95.6B | -1.75% | 10.00% | 23.41 | 0.71 | 10.74% | 2.64% |
CNC | 34.6B | 146.3B | -5.87% | -23.41% | 23.33 | 0.24 | 9.81% | -0.94% |
MID-CAP | ||||||||
LHCG | 5.2B | 2.3B | 3.17% | 35.63% | 86.23 | 2.28 | 2.85% | -58.05% |
HQY | 4.7B | 861.7M | 2.36% | -9.64% | -178.64 | 5.42 | 13.90% | 40.97% |
PDCO | 2.6B | 6.4B | 0.49% | -14.18% | 13.26 | 0.41 | -0.52% | 16.73% |
SMALL-CAP | ||||||||
RDNT | 1.7B | 1.5B | 6.01% | 44.82% | -126.07 | 1.14 | 10.24% | -173.11% |
AMEH | 1.5B | 1.2B | -11.87% | -12.06% | 29.48 | 1.2 | 41.46% | -34.10% |
ADUS | 1.4B | 976.1M | -21.09% | 3.91% | 28.65 | 1.47 | 10.19% | 12.37% |
AHCO | 1.4B | 3.0B | -8.71% | -40.99% | 31.6 | 0.47 | 12.33% | -78.12% |
BKD | 645.6M | 2.9B | -18.53% | -39.08% | -3.53 | 0.22 | 7.97% | -101.02% |
JYNT | 203.8M | 107.9M | -12.73% | -11.73% | 55.31 | 1.89 | 25.86% | -9.15% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Revenue | 6.5% | 1,218 | 1,144 | 1,045 | 955 | 861 |
S&GA Expenses | 11.9% | 87.00 | 78.00 | 70.00 | 70.00 | 65.00 |
EBITDA | 43.7% | 112 | 78.00 | 30.00 | 82.00 | - |
EBITDA Margin | -84.3% | 0.01* | 0.10* | - | - | - |
Earnings Before Taxes | 1.3% | 88.00 | 87.00 | 54.00 | 7.00 | 75.00 |
EBT Margin | -91.6% | 0.01* | 0.09* | - | - | - |
Interest Expenses | 27.7% | 10.00 | 8.00 | 6.00 | 5.00 | 5.00 |
Net Income | 0.7% | 49.00 | 49.00 | 65.00 | 74.00 | 75.00 |
Net Income Margin | -11.4% | 0.08* | 0.09* | - | - | - |
Free Cahsflow | 248.5% | 59.00 | -39.86 | 41.00 | 48.00 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Assets | 3.0% | 993 | 964 | 943 | 951 | 912 |
Current Assets | 5.2% | 458 | 435 | 444 | 461 | 444 |
Cash Equivalents | -4.7% | 275 | 288 | 184 | 234 | 238 |
Goodwill | 0.1% | 276 | 276 | 257 | 253 | 252 |
Liabilities | 4.9% | 415 | 395 | 390 | 425 | 381 |
Current Liabilities | 12.0% | 165 | 147 | 156 | 185 | 160 |
LT Debt, Current | 0.3% | 1.00 | 1.00 | 3.00 | 2.00 | 2.00 |
LT Debt, Non Current | 0.8% | 205 | 203 | 199 | 199 | 183 |
Shareholder's Equity | 1.9% | 563 | 553 | 510 | 486 | 480 |
Retained Earnings | 7.6% | 207 | 193 | 195 | 169 | 158 |
Additional Paid-In Capital | -2.1% | 353 | 360 | 315 | 311 | 316 |
Shares Outstanding | 3.8% | 47.00 | 45.00 | 45.00 | 45.00 | - |
Minority Interest | 44.0% | 3.00 | 2.00 | 3.00 | 6.00 | 6.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Cashflow From Operations | -19.9% | 66.00 | 82.00 | -15.00 | 72.00 | 84.00 |
Share Based Compensation | 2.4% | 16.00 | 16.00 | 13.00 | 11.00 | 8.00 |
Cashflow From Investing | 80.0% | -1.42 | -7.11 | 19.00 | 14.00 | -3.88 |
Cashflow From Financing | -38.0% | -27.72 | -20.08 | -24.52 | -29.29 | -48.48 |
Dividend Payments | 10.7% | 14.00 | 13.00 | 23.00 | 32.00 | - |
Buy Backs | -2.5% | 9.00 | 9.00 | 10.00 | 12.00 | 6.00 |
91.9%
91.2%
68.8%
Y-axis is the maximum loss one would have experienced if Apollo Medical Holdings was unfortunately bought at previous high price.
47.1%
18.1%
20.5%
FIve years rolling returns for Apollo Medical Holdings.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-05-22 | AMERIPRISE FINANCIAL INC | reduced | -3.46 | 871,263 | 5,464,260 | -% |
2023-05-18 | JPMORGAN CHASE & CO | added | 16.72 | 926,000 | 3,039,000 | -% |
2023-05-18 | NEW YORK STATE COMMON RETIREMENT FUND | reduced | -26.65 | -80,000 | 746,000 | -% |
2023-05-17 | Thrivent Financial for Lutherans | reduced | -4.31 | 216,000 | 1,421,000 | -% |
2023-05-16 | JANE STREET GROUP, LLC | added | 100 | 462,210 | 776,811 | -% |
2023-05-16 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | new | - | 631,004 | 631,004 | -% |
2023-05-16 | Rockefeller Capital Management L.P. | sold off | -100 | -71,000 | - | -% |
2023-05-16 | HANCOCK WHITNEY CORP | reduced | -12.67 | 38,000 | 546,000 | 0.02% |
2023-05-15 | VANGUARD GROUP INC | added | 6.18 | 40,544,300 | 171,893,000 | -% |
2023-05-15 | PNC Financial Services Group, Inc. | added | 78.8 | 36,795 | 67,361 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 09, 2023 | vanguard group inc | 7.83% | 4,438,955 | SC 13G/A | |
Jan 26, 2023 | blackrock inc. | 11.5% | 6,514,440 | SC 13G/A | |
Jan 20, 2023 | blackrock inc. | 11.5% | 6,514,440 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 7.02% | 3,897,315 | SC 13G | |
Jan 28, 2022 | blackrock inc. | 10.7% | 5,960,508 | SC 13G/A | |
Oct 08, 2021 | blackrock inc. | 10.6% | 5,867,352 | SC 13G | |
Jul 08, 2021 | allied physicians of california, a profession medical corp | 20.0% | 10,993,301 | SC 13D/A | |
Feb 25, 2020 | allied physicians of california, a profession medical corp | 33.0% | 17,517,288 | SC 13D/A | |
Feb 24, 2020 | lam thomas s. | 3.7% | 1,966,907 | SC 13D/A | |
Feb 24, 2020 | sim kenneth t. | 3.7% | 1,960,856 | SC 13D/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | - - | - - | - - | - - | - - |
Current Inflation | 32.25 3.13% | 40.64 29.96% | 72.34 131.34% | 117.74 276.53% | 196.51 528.43% |
Very High Inflation | - - | - - | - - | - - | - - |
Date Filed | Form Type | Document | |
---|---|---|---|
May 25, 2023 | 4 | Insider Trading | |
May 25, 2023 | 4 | Insider Trading | |
May 10, 2023 | 10-Q | Quarterly Report | |
May 08, 2023 | 8-K | Current Report | |
Apr 28, 2023 | DEF 14A | DEF 14A | |
Mar 15, 2023 | 4 | Insider Trading | |
Mar 13, 2023 | 8-K | Current Report | |
Mar 13, 2023 | 4 | Insider Trading | |
Mar 01, 2023 | 10-K | Annual Report | |
Feb 23, 2023 | 8-K | Current Report |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-14 | Marsh Linda | back to issuer | -9,539,260 | 35.32 | -270,081 | - |
2023-03-09 | Marsh Linda | acquired | 625,000 | 10.00 | 62,500 | - |
2022-12-12 | Vong John | acquired | - | - | 4,164 | svp-chief accounting officer |
2022-12-08 | Sim Kenneth T. | acquired | 1,048,910 | 10.4857 | 100,032 | executive chairman |
2022-12-07 | ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp | acquired | 1,128,250 | 10.4857 | 107,599 | president and co-ceo |
2022-12-05 | Lam Thomas S. | acquired | 1,048,860 | 10.4857 | 100,028 | president and co-ceo |
2022-12-02 | Lam Thomas S. | sold | - | - | -984,042 | president and co-ceo |
2022-12-02 | Young Albert WaiChow | acquired | - | - | 19,506 | chief administrative officer |
2022-12-02 | Sim Kenneth T. | acquired | - | - | 37,439 | executive chairman |
2022-12-02 | ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp | sold | - | - | -984,042 | - |
CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2023 | Mar. 31, 2022 | |
Revenue | ||
Total revenue | $ 337,244 | $ 263,258 |
Operating expenses | ||
Cost of services, excluding depreciation and amortization | 289,397 | 220,730 |
General and administrative expenses | 21,182 | 11,943 |
Depreciation and amortization | 4,292 | 4,374 |
Total expenses | 314,871 | 237,047 |
Income from operations | 22,373 | 26,211 |
Other (expense) income | ||
Income from equity method investments | 2,484 | 1,433 |
Interest expense | (3,269) | (1,073) |
Interest income | 3,009 | 46 |
Unrealized loss on investments | (6,392) | (8,962) |
Other income | 1,204 | 613 |
Total other expense, net | (2,964) | (7,943) |
Income before provision for income taxes | 19,409 | 18,268 |
Provision for income taxes | 5,102 | 6,195 |
Net income | 14,307 | 12,073 |
Net loss attributable to non-controlling interest | (315) | (2,191) |
Net income attributable to Apollo Medical Holdings, Inc. | $ 14,622 | $ 14,264 |
Earnings per share – basic (in dollars per share) | $ 0.31 | $ 0.32 |
Earnings per share – diluted (in dollars per share) | $ 0.31 | $ 0.31 |
Capitation, net | ||
Revenue | ||
Total revenue | $ 300,204 | $ 222,060 |
Risk pool settlements and incentives | ||
Revenue | ||
Total revenue | 13,462 | 18,075 |
Management fee income | ||
Revenue | ||
Total revenue | 9,896 | 10,473 |
Fee-for-service, net | ||
Revenue | ||
Total revenue | 12,062 | 11,095 |
Other income | ||
Revenue | ||
Total revenue | $ 1,620 | $ 1,555 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 | ||
---|---|---|---|---|
Current assets | ||||
Cash and cash equivalents | $ 274,613 | $ 288,027 | ||
Investments in marketable securities | 4,114 | 5,567 | ||
Receivables, net | 79,003 | 52,629 | ||
Receivables, net – related parties | 74,877 | 65,147 | ||
Income taxes receivable | 9 | 4,015 | ||
Other receivables | 1,929 | 1,834 | ||
Prepaid expenses and other current assets | 22,170 | 14,798 | ||
Loans receivable | 973 | 996 | ||
Loan receivable – related party | 0 | 2,125 | ||
Total current assets | 457,688 | 435,138 | ||
Non-current assets | ||||
Land, property, and equipment, net | 113,361 | 108,536 | ||
Intangible assets, net | 77,675 | 76,861 | ||
Goodwill | 276,028 | 275,675 | ||
Investments in other entities – equity method | 43,108 | 40,299 | ||
Investments in privately held entities | 896 | 896 | ||
Operating lease right-of-use assets | 18,431 | 20,444 | ||
Other assets | 5,441 | 6,056 | ||
Total non-current assets | 534,940 | 528,767 | ||
Total assets | [1] | 992,628 | 963,905 | |
Current liabilities | ||||
Accounts payable and accrued expenses | 49,486 | 49,562 | ||
Fiduciary accounts payable | 8,976 | 8,065 | ||
Medical liabilities | 101,394 | 84,253 | ||
Dividend payable | 664 | 664 | ||
Finance lease liabilities | 579 | 594 | ||
Operating lease liabilities | 3,234 | 3,572 | ||
Current portion of long-term debt | 621 | 619 | ||
Total current liabilities | 164,954 | 147,329 | ||
Non-current liabilities | ||||
Deferred tax liability | 3,695 | 3,042 | ||
Finance lease liabilities, net of current portion | 1,136 | 1,275 | ||
Operating lease liabilities, net of current portion | 18,164 | 19,915 | ||
Long-term debt, net of current portion and deferred financing costs | 204,944 | 203,389 | ||
Other long-term liabilities | 21,806 | 20,260 | ||
Total non-current liabilities | 249,745 | 247,881 | ||
Total liabilities | [1] | 414,699 | 395,210 | |
Commitments and contingencies (Note 12) | ||||
Mezzanine equity | ||||
Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation | 14,729 | 13,682 | ||
Stockholders’ equity | ||||
Common stock, $0.001 par value per share; 100,000,000 shares authorized, 46,488,443 and 46,575,699 shares issued and outstanding, excluding 10,569,340 and 10,299,259 treasury shares, as of March 31, 2023 and December 31, 2022, respectively | 47 | 47 | ||
Additional paid-in capital | 352,697 | 360,097 | ||
Retained earnings | 207,300 | 192,678 | ||
Total stockholders’ equity | 560,044 | 552,822 | ||
Non-controlling interest | 3,156 | 2,191 | ||
Total equity | 563,200 | 555,013 | ||
Total liabilities, mezzanine equity and equity | 992,628 | 963,905 | ||
Series A Preferred Stock | ||||
Stockholders’ equity | ||||
Preferred stock | 0 | 0 | ||
Series B Preferred Stock | ||||
Stockholders’ equity | ||||
Preferred stock | $ 0 | $ 0 | ||
|